Aimovig – Medicine Information

Aimovig

Also known as / Brand Names:

Aimovig (generic name: Erenumab-aooe)

Product Introduction:

Aimovig is a prescription medicine used for the prevention of migraine in adults. It is a monoclonal antibody that targets and blocks the calcitonin gene-related peptide (CGRP) receptor, which plays a critical role in migraine attacks. By preventing CGRP from binding to its receptor, Aimovig helps reduce the frequency and severity of migraine headaches. It is administered once a month via subcutaneous injection and is considered a major breakthrough in preventive migraine therapy.

Uses of Aimovig:

  • Prevention of episodic migraine
  • Prevention of chronic migraine

Benefits of Aimovig:

  • Reduces the number of migraine days per month
  • Improves quality of life and productivity
  • Convenient once-monthly dosing
  • May be effective in patients who have failed other preventive therapies

Side Effects of Aimovig:

  • Injection site reactions (pain, redness, swelling)
  • Constipation
  • Muscle spasms
  • Allergic reactions (rare)
  • High blood pressure (monitor regularly)
  • Fatigue

How to Use:

Aimovig is given as a subcutaneous injection once every month. It is available in prefilled autoinjector or syringe form. It can be self-administered after proper training or given by a healthcare provider. Typical doses are 70 mg or 140 mg monthly, depending on patient response and physician recommendation.

Safety Advice:

Condition Advice
Pregnancy CAUTION – Limited data available. Use only if clearly needed and under medical supervision.
Breastfeeding CAUTION – It is unknown if Aimovig passes into breast milk. Use only if benefits outweigh potential risks.
Driving SAFE – Does not affect alertness or coordination. You can drive after taking Aimovig.
Kidney SAFE – No dose adjustment needed for patients with kidney problems.
Liver SAFE – No dose adjustment required in patients with liver impairment.

Precautions & Warnings:

  • Inform your doctor if you have a history of constipation or bowel obstruction.
  • Monitor blood pressure regularly, especially in patients with hypertension.
  • Not recommended for use in children under 18 years of age.
  • Tell your doctor about all existing medications or conditions before starting Aimovig.

Interactions:

  • No significant drug interactions reported with Aimovig so far.
  • Still, inform your healthcare provider about any ongoing treatments, including over-the-counter drugs and supplements.

Storage:

Store Aimovig in the refrigerator at 2°C to 8°C. Do not freeze. If needed, Aimovig can be kept at room temperature (up to 25°C) for up to 7 days. Protect from light and keep the original packaging intact.

Important Reminder:
Remember, keep this and all other medicines out of the reach of children, never share your medicines with others, and use Aimovig only for the indication prescribed.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.